"Effectiveness of Non-invasive Neuromodulation Treatment for Improving Sexual Satisfaction in Healthy Subjects."

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

April 1, 2024

Study Completion Date

June 30, 2024

Conditions
Sexual Satisfaction
Interventions
DEVICE

Non-Invasive Neuromodulation (NESA)

Considering the objectives set: In the first phase, the directing electrode will be located at C6-C7 to generate a systemic and general effect on the organism, with program 1, program 2, program 7, and program 8. In the second phase, the directing electrode will be placed at the abdominal level in the area of the mesenteric plexus to influence the sympathetic innervation of the viscera. In the third phase, the directing electrode is located at S2-S3 to concentrate the action of the therapy on the sacral parasympathetic plexus,. In this way, both the sympathetic and parasympathetic innervation of the main sexual organs are covered through the sympathetic paravertebral ganglia and the sacral plexus.

Trial Locations (1)

Unknown

Universidad Europea de Madrod, Villaviciosa de Odón

All Listed Sponsors
lead

Universidad Europea de Madrid

OTHER

NCT06304558 - "Effectiveness of Non-invasive Neuromodulation Treatment for Improving Sexual Satisfaction in Healthy Subjects." | Biotech Hunter | Biotech Hunter